Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Approved Canadian Pharmacy - ShopMY.org. Best way to buy Generic Cialis online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
In a major landmark for advanced interventional technology to treat aortic disease, the Zenith® Branch Iliac Endovascular Graft has been used to treat the world’s 1,000th patient undergoing endovascular treatment for an aorto-iliac or iliac aneurysm. Mr Ferdinand Serracino-Inglott, one of only 200 vascular surgeons performing this type of surgery in Europe, carried out the minimally invasive endovascular procedure at Manchester Royal Infirmary.
|
20
Aug |
Total And Free PSA (PSA/fPSA) Assays Now Available For The Olympus AU3000i Immunoassay AnalyserCategory: Prostate / Prostate Cancer | Leave a Comment |
Olympus is pleased to announce the launch of highly sensitive and precise PSA (Prostate Specific Antigen) and fPSA assays for the Olympus AU3000i immunoassay analyser. The use of PSA and fPSA is well established in the screening and management of prostate cancer. Olympus is joining this market with an extremely sensitive PSA assay with a functional sensitivity of 0.015 µg/L.